Stockscreener 앱 받기
21.76
2.94%
-0.66
시간 외 거래:
21.76
전일 마감가:
$22.42
열려 있는:
$22.44
하루 거래량:
731.22K
Relative Volume:
0.78
시가총액:
$3.76B
수익:
-
순이익/손실:
$-100.44M
주가수익비율:
-9.8018
EPS:
-2.22
순현금흐름:
$-105.32M
1주 성능:
-11.36%
1개월 성능:
-16.02%
6개월 성능:
-34.36%
1년 성능:
-35.55%
1일 변동 폭
$21.51
$22.59
1주일 범위
$21.51
$24.98
52주 변동 폭
$13.22
$62.74
Structure Therapeutics Inc Adr Stock (GPCR) Company Profile
명칭
Structure Therapeutics Inc Adr
전화
(628) 229-9277
주소
611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO
GPCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GPCR
Structure Therapeutics Inc Adr
|
21.76 | 1.41B | 0 | -100.44M | -105.32M | -2.22 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-02 | 개시 | Citigroup | Buy |
| 2025-02-28 | 개시 | William Blair | Outperform |
| 2025-01-08 | 개시 | Stifel | Buy |
| 2024-12-04 | 개시 | H.C. Wainwright | Buy |
| 2024-09-23 | 개시 | Morgan Stanley | Overweight |
| 2024-05-21 | 개시 | JP Morgan | Overweight |
| 2024-04-09 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-19 | 개시 | JMP Securities | Mkt Outperform |
| 2023-07-27 | 개시 | Piper Sandler | Overweight |
| 2023-05-25 | 재개 | Jefferies | Buy |
| 2023-02-28 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-28 | 개시 | Guggenheim | Buy |
| 2023-02-28 | 개시 | Jefferies | Buy |
| 2023-02-28 | 개시 | SVB Securities | Outperform |
모두보기
Structure Therapeutics Inc Adr 주식(GPCR)의 최신 뉴스
Structure Therapeutics Set for Jefferies and Goldman Sachs Healthcare Conference Presentations in June - Stock Titan
Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints - standard-journal.com
Bank of America Corp DE Sells 48,015 Shares of iShares MSCI Australia ETF (NYSEARCA:EWA) - Defense World
BNP Paribas Financial Markets Makes New $304,000 Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Analysts Have Conflicting Sentiments on These Healthcare Companies: Novo Nordisk (NVO), Beam Therapeutics (BEAM) and TScan Therapeutics (TCRX) - The Globe and Mail
Structure Therapeutics’ SWOT analysis: oral obesity drug stock poised for growth - Investing.com
Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $78.00 - Defense World
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Relmada Therapeutics (RLMD) and Roivant Sciences (ROIV) - The Globe and Mail
Structure Therapeutics (NASDAQ:GPCR) Price Target Lowered to $75.00 at HC Wainwright - Defense World
FY2025 Earnings Forecast for GPCR Issued By Leerink Partnrs - Defense World
Envestnet Asset Management Inc. Has $201,000 Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Tower Research Capital LLC TRC Acquires 3,549 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - The AM Reporter
Structure Therapeutics Reports Increased Losses Amid Rising R&D Costs - TipRanks
Structure Therapeutics Reports First Quarter 2025 Financial Results and Recent Highlights - Stock Titan
Wells Fargo & Company MN Boosts Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Analyzing Ratios: Structure Therapeutics Inc ADR (GPCR)’s Financial Story Unveiled - DWinneX
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), AnaptysBio (ANAB) and Alignment Healthcare (ALHC) - The Globe and Mail
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Is Up 1.57% So Far This Year: What Will Happen Next? - Stocksregister
Structure Therapeutics (NASDAQ:GPCR) Research Coverage Started at Citigroup - Defense World
Structure Therapeutics Inc ADR (GPCR) expanding its growth trajectory ahead - Sete News
Buy Recommendation for Structure Therapeutics: Promising Pipeline and Obesity Treatment Market Potential - TipRanks
Citi sets Structure Therapeutics stock Buy rating, $60 target By Investing.com - Investing.com India
Technical analysis of Stoke Therapeutics Inc (STOK) stock chart patterns - uspostnews.com
Terns Pharmaceuticals Inc (TERN) deserves deeper analysis - uspostnews.com
A stock that deserves closer examination: Structure Therapeutics Inc ADR (GPCR) - uspostnews.com
What is the investor’s view on LSB Industries, Inc (LXU)? - uspostnews.com
Geode Capital Management LLC Increases Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
The Potential Rise in the Price of Structure Therapeutics Inc ADR (GPCR) following insiders activity - knoxdaily.com
A Guide To The Risks Of Investing In Jamf Holding Corp (JAMF) - knoxdaily.com
GPCR Stock: A Voyage Through Structure Therapeutics Inc ADR’s Finances - investchronicle.com
Recent Insider Activity Could Benefit Pacific Premier Bancorp, Inc (PPBI) - knoxdaily.com
Barclays PLC Increases Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
24,530 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Mariner LLC - Defense World
Market Update: CytomX Therapeutics Inc (CTMX) Sees Negative Movement, Closing at 0.71 - DWinneX
Stock Market Recap: Barrick Gold Corp (GOLD) Concludes at 19.30, a 1.31 Surge/Decline - DWinneX
Market Resilience: ReShape Lifesciences Inc (RSLS) Finishes Weak at 0.36, Down -0.85 - DWinneX
Gaining Ground: Structure Therapeutics Inc ADR (GPCR) Closes Lower at 23.62, Down -0.51 - DWinneX
JPMorgan Chase & Co. Has $876,000 Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Acquired by LPL Financial LLC - Defense World
LPL Financial LLC Has $341,000 Stock Holdings in AdvisorShares Dorsey Wright FSM All Cap World ETF (NASDAQ:DWAW) - American Banking and Market News
Is Structure Therapeutics Inc. (NASDAQ:GPCR) the Most Promising Small-Cap Stock According to Analysts? - Yahoo Finance
Is Edgewise Therapeutics Inc. (NASDAQ:EWTX) the Most Promising Small-Cap Stock According to Analysts? - Yahoo Finance
Structure Therapeutics’ (GPCR) “Buy” Rating Reiterated at HC Wainwright - Defense World
Daily Progress: Structure Therapeutics Inc ADR (GPCR) Drop -11.51, Closing at 21.03 - DWinneX
Structure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Rating of “Buy” by Analysts - The AM Reporter
Metric Analysis: Silvercorp Metals Inc (SVM)’s Key Ratios in the Limelight - DWinneX
Ratios Revealed: Decoding Structure Therapeutics Inc ADR (GPCR)’s Financial Health - DWinneX
Invesco Ltd. Grows Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
A Guide To The Risks Of Investing In Structure Therapeutics Inc ADR (GPCR) - knoxdaily.com
How should investors view Nano X Imaging Ltd (NNOX)? - uspostnews.com
Complete Solaria Inc (CSLR) produces promising results - uspostnews.com
Structure Therapeutics Inc Adr (GPCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.89%
3.74%
자본화:
|
볼륨(24시간):